SHPAX Mutual Fund
SHPAX Mutual Fund
SHPAX Mutual Fund
Saratoga Health & Biotechnology Portfolio Class A
SHPAX Mutual Fund Overview
SHPAX Mutual Fund (Saratoga Health & Biotechnology Portfolio Class A) is managed by Saratoga Capital Management, LLC with $5.3M in net assets. SHPAX expense ratio is 3.00%, holding 30 positions across sectors including Health Care, Financials. Inception date: 1999-07-15.
SHPAX performance shows a YTD return of 7.07%. The 1-year return is 28.44% and the 5-year return is 5.62%. SHPAX dividend yield stands at 3.41%, paid annually.
SHPAX top holdings include Cardinal Health Inc. (7.3%), Jazz Pharmaceuticals Plc. (6.0%), United Therapeutics Corp (5.7%), Amgen Inc. (5.1%), Lantheus Holdings Inc (4.9%). Go to all SHPAX holdings, SHPAX sectors, or SHPAX dividends.
SHPAX can be compared against other funds. Use SHPAX overlap to find shared positions, or SHPAX vs another fund for a side-by-side view. SHPAX alternatives are available via the screener, along with tax-loss harvesting opportunities.